Related Experiment Video

Updated: Jan 14, 2026

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

8.0K

Retraction: miR-335 targets LRRK2 and mitigates inflammation in Parkinson's disease

    Frontiers in Cell and Developmental Biology
    |October 22, 2025
    PubMed

    Insights

    This article has been retracted. The original study is no longer considered valid scientific literature.

    Area of Science:

    • Cellular Biology
    • Molecular Biology

    Background:

    • The original study investigated cellular processes.
    • Key findings were previously published.

    Purpose of the Study:

    • To present novel research in cell biology.
    • To contribute to the understanding of cellular mechanisms.

    Main Methods:

    • Standard laboratory techniques were employed.
    • Data analysis followed established protocols.

    Main Results:

    • The original findings are now invalidated.
    • The retraction indicates issues with the study's integrity.

    Conclusions:

    • The article is retracted due to undisclosed reasons.
    • This retraction removes the study from the scientific record.

    More Related Videos

    Assaying the Kinase Activity of LRRK2 in vitro06:09

    Assaying the Kinase Activity of LRRK2 in vitro

    Published on: January 18, 2012

    22.9K
    The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease15:09

    The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

    Published on: October 3, 2012

    17.3K

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    972
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
    1.7K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    5.3K